Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KTP Laser +/- Ivermectin for Facial Rosacea
NCT06033352Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Sep 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in rosacea, sponsored by Insel Gruppe. Started Sep 2023; status: completed.
02
Drugs
ivermectin
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT06033352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06033352.